Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: The EXAMI study

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 289-290

  Bernink, Flip J P ^a   Timmers, Leo ^b   Diamant, Michaela ^a   Scholte, Martijn ^c   Beek, Aernout M ^a   Kamp, Otto ^a   Marques, Koen M J ^a   Denham, Robert N ^a   Chen, Weena J Y ^a   Doevendans, Pieter A ^b   Van Rossum, Albert C ^a   Van Royen, Niels ^a   Horrevoets, Anton J G ^a   Appelman, Yolande ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Acute myocardial infarction; Exenatide; Glucagon like peptide 1; Percutaneous coronary intervention; Reperfusion injury

Indexed keywords

EXENDIN 4; PLACEBO;

ACUTE HEART INFARCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CONTINUOUS INFUSION; DRUG MEGADOSE; GLYCEMIC CONTROL; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LETTER; LOADING DRUG DOSE; LOW DRUG DOSE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84878525375     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.204     Document Type: Article

References (9)

1. R.J. Burns, R.J. Gibbons, and Q. Yi The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis J Am Coll Cardiol 39 1 Jan 2, 2002 30 36
2. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 9351 Jan 4, 2003 13 20
3. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 11 Sep 13, 2007 1121 1135
4. Y. Wei, and S. Mojsov Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences FEBS Lett 358 3 Jan 30, 1995 219 224
5. T. Zhao, P. Parikh, and S. Bhashyam Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts J Pharmacol Exp Ther 317 3 Jun 2006 1106 1113
6. A.K. Bose, M.M. Mocanu, R.D. Carr, C.L. Brand, and D.M. Yellon Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury Diabetes 54 1 Jan 2005 146 151
7. R.E. van Genugten, D.H. van Raalte, and M. Diamant Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide Diabetes Res Clin Pract 86 Suppl. 1 Dec 2009 S26 S34
8. J. Lonborg, N. Vejlstrup, and H. Kelbaek Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 12 Jun 2012 1491 1499
9. M. Scholte, L. Timmers, and F.J. Bernink Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial Trials 12 2011 240